BMS-Sponsored Diversity in Oncology Series Tackles Representation in Clinical Trials

On March 30, clinical trial leaders, hospital practitioners and patient representatives met in the latest installment of the Diversity in Oncology series hosted by GRYT Health and Bristol Myers Squibb. The purpose: to uncover barriers to clinical trial access and work toward actionable structural improvements and solutions.